Serum IgG and IgA antibodies to Chlamydia pneumoniae and severity of emphysema (Q37863634)

24 August 2017

title

Serum IgG and IgA antibodies to Chlamydia pneumoniae and severity of emphysema (English)

1 reference

24 August 2017

1 reference

Chlamydia pneumoniae

1 reference

Kazuyoshi Kurashima

1

1 reference

24 August 2017

Tetsu Kanauchi

2

1 reference

24 August 2017

Noboru Takayanagi

3

1 reference

24 August 2017

Nagato Sato

4

1 reference

24 August 2017

Daido Tokunaga

5

1 reference

24 August 2017

Mikio Ubukata

6

1 reference

24 August 2017

Tsutomu Yanagisawa

7

1 reference

24 August 2017

Yutaka Sugita

8

1 reference

24 August 2017

Minoru Kanazawa

9

1 reference

24 August 2017

publication date

1 November 2005

1 reference

24 August 2017

1 reference

24 August 2017

volume

10

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

572-578

1 reference

Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

Chlamydia pneumoniae enhances cytokine-stimulated human monocyte matrix metalloproteinases through a prostaglandin E2-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

Immunohistochemical staining for Chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

A quantification of the lung surface area in emphysema using computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

Complexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

The effects of age, sex, lung size, and hyperinflation on CT lung densitometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

Detection of serum antibodies against Chlamydia pneumoniae by ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 1. Evaluation of ELISA kit using outer membrane complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 2. studies on clinical usefulness and serological diagnostic standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

The role of chlamydia in the pathogenesis of pulmonary emphysema. Electron microscopy and immunofluorescence reveal corresponding findings as in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

Persistent infection with Chlamydia pneumoniae following acute respiratory illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

Radiologic evaluation of emphysema in patients with chronic obstructive pulmonary disease. Chest radiography versus high resolution computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00752.X

10.1111/J.1440-1843.2005.00752.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference